Everything below concerns Ac-LKKTETQ. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2026-06-06. Where a claim depends on a specific study, the study is described rather than over-claimed.
TB-500 is a research peptide whose sequence matches residues 17 to 23 of thymosin beta-4, a 43-residue protein present in most mammalian cells. The chain is seven amino acids long, written as LKKTETQ, and is normally supplied with an acetyl group on the N-terminus. Suppliers list it as a lyophilised powder under the code name TB-500, and the same sequence appears elsewhere in catalogues as the thymosin beta-4 actin-binding fragment. The label is commercial rather than systematic, so no single authority fixes exactly what TB-500 denotes.
Thymosin beta-4 was isolated from calf thymus in the early 1980s and later characterised as an abundant intracellular actin-sequestering protein. Interest in short synthetic fragments grew once the actin-binding motif had been mapped to the middle of the sequence. TB-500 came out of that line of work as a truncated analogue rather than a natural isolate, and it is now sold mainly to laboratories. Published studies on the fragment have been largely in vitro or in animal models, and controlled human trials remain sparse, so claims about effects in people rest on extrapolation.
Literature and online discussion often conflate TB-500 with full-length thymosin beta-4, even though the two differ in size and are not interchangeable in analytical terms. The fragment is produced by solid-phase peptide synthesis, and the product is a defined seven-residue chain rather than a biological extract. Because the term is a trade-style label, two vendors may supply materials of the same nominal sequence but different counter-ion content, purity, or water content. Comparisons across studies are therefore difficult unless the exact sequence and purity are reported.
TB-500 is a synthetic heptapeptide with the sequence Ac-LKKTETQ. It corresponds to a short N-terminal region of thymosin beta-4, a 43-amino-acid protein found in many cell types. The fragment contains an actin-binding motif, which is one reason it appears in laboratory studies of cell migration and cytoskeletal dynamics. TB-500 is not the full-length protein and is produced as a research chemical rather than an approved therapeutic agent. Its molecular weight is approximately 889 Da.
Several names appear in scientific and commercial contexts for this peptide. The label TB-500 is informal and does not follow standard biochemical nomenclature. Research articles more often describe the compound as a thymosin beta-4 fragment, Tβ4 fragment, or by its sequence Ac-LKKTETQ. Confusing TB-500 with full-length thymosin beta-4 can lead to incorrect assumptions about activity because the fragment lacks the remaining residues of the parent protein. The relationship between fragment and parent protein remains an active area of study.
Regulatory status differs by country, but TB-500 is not an approved pharmaceutical in major jurisdictions. It is commonly sold as a research chemical for laboratory use, which places responsibility for identity and purity on the supplier and the laboratory. Published human data are limited, and most reports involve preclinical models or cell culture. Questions about whether the fragment mimics all actions of thymosin beta-4, and under which conditions, remain open. Independent verification of any material is therefore a practical requirement in research settings.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Supplied as a lyophilised cake in sealed vials |
| Solubility class | Freely soluble in water | Polar and charged side chains dominate the sequence |
| Typical storage temperature | -20 °C or below | Dry and dark; a desiccant is often recommended |
| Identity confirmation | Mass spectrometry | Observed mass compared with the theoretical value |
| Common synonyms | Thymosin beta-4 fragment | Also written as T beta 4 fragment 17-23 |
The compound is most often distributed as a lyophilized powder, appearing white to off-white and forming a loose cake or fluffy solid. It is hygroscopic to some degree, so brief exposure to humid air can add water weight and complicate weighing. The peptide dissolves readily in water and in neutral aqueous buffers, and aqueous solubility is generally described as high, well above the concentrations used in typical assays. Some polar organic solvents are also usable, which matters when a concentrated stock is prepared before dilution into buffer.
Storage recommendations center on keeping the dry powder cold, dry, and dark. A freezer at -20 degrees Celsius or below is conventional, and desiccant is often included to limit moisture uptake. Once dissolved, the peptide is less stable, and solutions are typically kept frozen and thawed only once. Repeated freeze-thaw cycles are a common source of losses because they promote aggregation and adsorption to container surfaces. Working aliquots are therefore prepared in advance, and glass or low-binding plastic is usually preferred over ordinary laboratory plastic.
Reconstitution of a lyophilized peptide is normally done with sterile water or a suitable buffer under aseptic conditions. Adding solvent down the vial wall and allowing gentle dissolution instead of vigorous vortexing reduces the chance of aggregation, which can lower the effective concentration of the resulting solution. Concentrated stocks are usually diluted into working buffer shortly before use. Because no standard preparation protocol exists for TB-500 specifically, laboratories adapt general peptide handling practice, and reported results may reflect differing preparation choices.
Dry peptide powder is commonly kept at −20 °C in a desiccated container away from light, a practice that limits moisture uptake and oxidation. Once dissolved, solutions are generally held at 2–8 °C for short periods or frozen at −20 °C or lower for longer storage, with repeated freeze-thaw cycles avoided. Hydrolysis and oxidation are the main degradation routes for peptides in solution, and both accelerate at higher temperature or extreme pH. Published stability data specific to TB-500 are limited, so shelf life should be treated as uncertain.
A broad-spectrum chemokine inhibitor (BSCI), also termed chemotide or somatotaxin, is a type of experimental anti-inflammatory drug that inhibits the action of the pro-inflammatory proteins chemokines. Radiolabeling experiments performed by Dr. David Fox, University of Warwick, demonstrated the ability of the BSCI to bind and antagonize the somatostatin receptor 2 (SSTR2). This is a display of functional selectivity at the SSTR2 receptor. Functional selectivity is the effect of one ligand having one agonism when bound to the receptor and another ligand having a different agonism at that same receptor.
== EMAIL invention controversy == Ayyadurai is notable for his widely disputed claim of being the "inventor of email". His claim is based on an electronic mail software called EMAIL, an implementation of interoffice email system, which he wrote as a 14-year-old student at Livingston High School, New Jersey, in 1979. Initial reports that repeated Ayyadurai's assertion—from organizations such as The Washington Post and the Smithsonian Institution—were followed by public retractions. These corrections were triggered by objections from historians and ARPANET pioneers who cited the fact the history of email dated back to the early 1970s. Ayyadurai started a campaign in 2011 in which he rebranded himself as the "Inventor of Email"; according to a paper published in Information & Culture, he "provoked a dramatic succession of exaggerated claims, credulous reporters, retractions, and accusations that a cabal of industry insiders and corrupt Wikipedia editors are colluding to hide the truth." A November 2011 Time Techland interview by Doug Aamoth, entitled "The Man Who Invented Email", argued that EMAIL represented the birth of email "as we currently know it". In that interview, Ayyadurai recalled that Les Michelson, the former particle scientist at Brookhaven National Labs who assigned Ayyadurai the project, had the idea of creating an electronic mail system that uses the header conventions of a hardcopy memorandum. Ayyadurai recalled Michelson as saying: "Your job is to convert that into an electronic format.
The e-cigarette vapor is generated when the e-liquid is vaporized by the heating element or by other mechanical methods. The last step of vapor processing happens as the e-cigarette vapor passes through the main air passage to the user. For some advanced devices, before inhaling, the user can adjust the heating element temperature, air flow rate or other features. The liquid within the chamber of an e-cigarette is heated to roughly 100-250 °C to create an aerosolized vapor. This is thought to result in pyrolysis of the e-liquid and could also lead to decomposition of other liquid ingredients. The aerosol (mist) produced by an e-cigarette is commonly but inaccurately called vapor. In physics, a vapor is a substance in the gas phase whereas an aerosol is a suspension of tiny particles of liquid, solid or both within a gas. The power output of the e-cigarette is correlated to the voltage and resistance (P = V2/R, in watts), which is one aspect that impacts the production and the amount of toxicants of e-cigarette vapors. The power generated by the heating coil is not based solely on the voltage because it also relies upon the current, and the resultant temperature of the e-liquid relies upon the power output of the heating element. The production of vapor also relies upon the boiling point of the solvent. Propylene glycol boils at 188 °C, while glycerin boils at 290 °C. The higher temperature reached by glycerin may impact the toxicants emitted by the e-cigarette. The boiling point for nicotine is 247 °C.
Sources: en.wikipedia.org
Numerous events are hosted on the lawn at Bryant Park. Bryant Park Movie Nights, begun in the early 1990s, take place on Monday evenings during the summer. Various free musical performances are sponsored by corporations during months with warm weather, including Broadway in Bryant Park, sponsored by iHeartMedia and featuring performers from current Broadway musicals, integrated with content provided by event sponsors. The park has various activity areas open all day long, including board games, chess and backgammon, a putting green and Kubb area, an Art Cart, ping pong tables, and Petanque courts. The parks also offer free classes in juggling, yoga, tai chi, and knitting. In the 40th Street plaza of the park, there is a station called Bryant Park Games where visitors can borrow an array of games, including Chinese chess and quoits. In addition, chess and table tennis can also be played at Bryant Park. Food and drink are served at four park-operated concessionary kiosks. There are two additional kiosks on Fifth Avenue, bringing the total of concessionaires near Bryant Park to six.
=== Ch–Che === Michael Chamberlin (1937–2025). American molecular biologist at UC Berkeley, with research focussed on gene expression in both prokaryotes and eukaryotes. Member Natl. Acad. Sci. USA. Britton Chance (1913–2010). American biochemist at the University of Pennsylvania. He studied enzyme structure and function, and invented the stopped-flow spectrophotometer for studying fast reactions. Member Natl. Acad. Sci. USA. Christopher Chang (b. 1974). American bioinorganic chemist at UC Berkeley. His research includes molecular imaging sensors for the study of redox biology. Jean-Pierre Changeux (b. 1936). French biochemist and neuroscientist at the Collège de France and Institut Pasteur. Originator of the allosteric model of cooperativity, but now known mainly for work in neuroscience. Emmett Chappelle (1925–2019). American biochemist at NASA, known for using bioluminescence to develop a method of detecting ATP. Erwin Chargaff (1905–2002). Austrian-American biochemist at Columbia, known for Chargaff's rules, according to the first of which the number of guanine units in DNA is equal to the number of cytosine units, and the number of adenine units is equal to the number of thymine units. Emmanuelle Charpentier (b. 1968). French microbiologist, geneticist and biochemist. She (with Jennifer Doudna) discovered genome editing with CRISPR. Nobel Prize for Chemistry in 2020. Foreign Associate Natl. Acad. Sci. USA Martha Chase (1927–2003).
There have been numerous proposals and usage of decimal time, most of which were based on the day as the base unit. In dynastic China, the kè was a unit that represented 1⁄100 of a day (since redefined to 1⁄96 of a day, or 15 minutes). In France, a decimal time system in place from 1793 to 1805 divided the day into 10 hours, each divided into 100 minutes, in turn divided into 100 seconds; the French Republican calendar further extended this by assembling days into ten-day weeks. Ordinal dates and Julian days, the latter of which has seen use in astronomy as it is not subject to leap year complications, allow for the expression of a decimal portion of the day. Decimal time is frequently found in fiction, often in futuristic works. The Swatch Internet Time system is based on decimal time. Many mechanical stopwatches are of the 'decimal minute' type. These split one minute into 100 units of 0.6 s each. This makes addition and subtraction of times easier than using regular seconds.
Sources: en.wikipedia.org
Hyperpigmentation, also known as dark spots, is the darkening of an area of skin or nails caused by increased melanin. Many topical treatments disrupt the synthesis of melanin by inhibiting the enzyme tyrosine hydroxylase.
The current consumer price inflation in Europe and the United States is less than 2%, compared to India's double digit inflation. The Pepsi and Coca-Cola example is meaningless in the context of Indian beverage market. More competition is lacking because of limited demand. Indian consumer has limited interest in soft drinks. Soft drinks represent less than 5% of Indian beverage market. Indian consumers prefer milk-based, tea and coffee and these account for 90% of Indian beverage market, with plenty of competing domestic brands and even European brands like Nestlé. The next most important market in India is bottled water, which outsells the combined soft drink sales of the Pepsi and Coca-Cola. Organised retail too will have numerous brands and strong competition. Comparing the 21st century to the 18th century is inappropriate. Conditions today are different. India wasn't a democracy then. Global awareness and news media have also changed. For example, China has over 57 million square feet of retail space owned by foreigners, employing millions of Chinese citizens. Yet, China hasn't become a vassal of imperialists, enjoying respect from all global powers. Other Asian countries like Malaysia, Taiwan, Thailand and Indonesia see foreign retailers as catalysts of new technology and price reduction; and they have benefited by welcoming FDI in retail. India too will benefit by integrating with the world, rather than isolating itself. With 51% FDI limit in multi-brand retailers, nearly half of any profits will remain in India.
=== Acid coagulants === Glucono delta-lactone (GDL) is a naturally occurring organic acid also used in cheesemaking, this coagulant produces a very fine textured tofu that is almost jelly-like. It is used especially for "silken" and softer tofus and confers a faint sour taste to the finished product. GDL is derived from glucose and takes the form of a white powder at room temperature. Its molecular structure contains a six-membered heterocyclic ring that is hydrolyzed upon contact with water, slowly converting GDL to gluconic acid. When added to soy milk, it gradually lowers the pH and causes proteins to coagulate evenly throughout the mixture, forming a single, smooth gel that is free of air gaps and that resists breaking during transportation. Using GDL as a coagulant, silken tofu can be formed directly in its container, as it does not require pressing. This acid coagulant is also commonly used together with calcium sulfate to give soft tofu a smooth, tender texture. Other edible acids can be used. Though they can affect the taste of the tofu more, and vary in density and texture, acids such as acetic acid (vinegar) and citric acid (such as lemon juice), can also be used to coagulate soy milk and produce tofu.
Sources: en.wikipedia.org
No. Thymosin beta-4 is a 43-residue protein, while TB-500 matches only residues 17 to 23 of that chain. The two are related but differ in size, and a method that identifies one does not automatically identify the other.
It corresponds to the actin-binding region of thymosin beta-4. Commercial synthesis reproduces that seven-residue stretch, usually with an acetyl group on the N-terminus.
It is not authorised as a medicine in the United States or the European Union and is distributed as a research chemical. Labels consequently carry research-use-only statements rather than clinical indications.
TB-500 is a synthetic heptapeptide corresponding to a fragment of thymosin beta-4. It is used in laboratory research and is not an approved drug.